KYMRIAH is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse
Recommend0 recommendationsPublished in US National Health Agency Sources
This content is from the “Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings.” Increasing Diversity in Pediatric Cancer Clinical Trials Dr. Paula Aristizabal is Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology, Medical Director of the International Outreach Program, and Quality Improvement Lead at the University of California San …
The post Elevating the Research and Treatment Needs of Latino Children, Adolescents, and Young Adult Survivors appeared first on Salud America.
Cancer survival disparities are well documented in adults living along the US-Mexico border, but it is unknown whether these disparities similarly affect children with leukemia, the most common cancer in children and teens. A Baylor College of Medicine study in the journal Cancer helps bridge this knowledge gap. Let’s explore the findings of the study, …
The post Childhood Cancer Survival Rates Lower on Texas-Mexico Border; SDoH-Focused Cancer Research Needed appeared first on Salud America.
For the treatment of adult patients with relapsed or refractory (r/r) B-cell precursor acute lymphoblastic leukemia (B-ALL). For the treatment of adult patients with relapsed/refractory mantle cell lymphoma (r/r MCL).
“The good news is, we can’t kill you trying to save you. You showed up fit to fight.” Still in shock of recent events, Loriana Hernandez-Aldama tried to process the words of world-renowned oncologist Dr. Mark Levis. In such a short period of time in January 2014, her life had completely changed. Just a few …
The post Latina Warrior Beats Cancer, Saves Lives Through Education and Advocacy appeared first on Salud America.
Some big changes in 2022 and 2023 have set up the healthcare sector to advance screening for non-medical social needs in 2024 and beyond. This is great news as we work to address social determinants of health (SDoH), improve health outcomes, and reduce health disparities. But one key social need – transportation – isn’t getting …
The post As Social Need Screening Advances, Transportation Remains an Afterthought appeared first on Salud America.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
